Synthetic Biology Market: New Applications and case-study with Global Forecast 2022

According to the new market research report Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) – Global Forecast to 2022, published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.

Don’t miss out on business opportunities in Synthetic Biology Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2Aby8m5

The synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application. The pharmaceuticals subsegment is expected to account for the largest share of the market. However, biofuel and renewable energy is expected to grow at the highest CAGR during the forecast period owing to the global demand for fossil fuel alternatives and the advantages of the genetically engineered organisms for the synthetic production of biofuels.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the synthetic biology market and estimate the size of other dependent submarkets. Various secondary sources such as Centre for Synthetic Biology and Innovation (CSynBI), Institute of Systems and Synthetic Biology, University of California San Francisco (UCSF) Center for Systems & Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Synthetic Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Industry Association of Synthetic Biology (IASB), European association of synthetic biology, Society for Biological Engineering (SBE), Systems and Synthetic Biology Journal, Biological Sciences Research Council, expert interviews, and MarketsandMarkets Analysishave been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Browse and in-depth TOC on “Synthetic Biology Market”

162 – Tables

32 – Figures

214 – Pages

 

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html

The US is expected to dominate the synthetic biology market in 2017

In 2017, the US is estimated to account for the largest share among other regions in the synthetic biology market, followed by the UK and Germany. The dominant share of the US is attributed to factors such as increased demand for bio-based products, increased investments in synthetic biology companies, and rising R&D funding for synthetic biology.

Based on region, the synthetic biology market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is estimated to account for the largest share of the global market. Regarding growth rate, Europe is expected to register the highest growth rate from 2017 to 2022. Factors such as increasing investments for the adoption of adoption of novel synthetic biology technologies, rising R&D funding and collaborations are driving the growth of the market in this region.

While the overall market is expected to grow at a high rate, possible environmental and security issues related to synthetic biology is likely to restrain the growth of this market to a certain extent.

The major players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), among others.

Request for Free Sample Report @ http://bit.ly/2Abtap3

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/synthetic-biology-market.asp

Visit Our Website: https://www.marketsandmarkets.com